Global Laparoscopic Power Morcellators Market by Application (Myomectomy, Hysterectomy) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global laparoscopic power mortillators market was valued at USD 107.3 millions in 2020. It is expected to grow at a compound annual rate (CAGR of 7.4%) between 2021 and 2028. Market growth is expected to be driven by the increasing incidence of uterine fibroids in women worldwide, rising preference for minimally invasive procedures in gynecology, and technological advances in surgical devices. For cutting down tissues, power morcellators can be used during procedures like fibroid removal and hysterectomy.

The market for laparoscopic power morcellators has been moderately impacted by COVID-19 owing to delay or cancellation of numerous elective surgeries, including hysterectomy/myomectomy, as many hospitals closed outpatient facilities in order to limit the spread of the disease and prioritize the treatment of COVID-19 patients. This has resulted in a limited use of surgical devices in hospitals. However, the European Society for Gynecological Endoscopy and the American Association of Gynecologic Laparoscopists have issued guidelines to continue performing minimally/non-invasive surgery in case of emergency. The market for laparoscopic power mocellators is expected to see a significant increase in demand as the pandemic has ended.

Globally, uterine fibroids are increasing in prevalence. These can cause abnormal uterine bleeding, dysmenorrhea (painful, heavy periods), and pelvic and abdominal pressure. Around 50 to 75%, or 50%, of uterine fibroids suffer from symptoms. Many cases go undiagnosed. It is possible that 77% of women who are pregnant could have uterine fioids. An NCBI report estimates that around 30,000 myomectomies (fibroid) are performed each year in the United States. Uterine fibroids are more common as women get older. They may affect over 30% of women between 40 and 60 years old. According to the U.S. National Institutes of Health in 2017, 793,846 women were diagnosed as having uterine cancer. Uterine cancer cases increased by 27.8 per 100,000 women per year. This supports the development of uterine fibrid treatment. The rising number of uterine fibroids has led to an increase in the worldwide demand for myomectomy and hysterectomy procedures. This will boost the market for laparoscopic power mocellators during the forecast period.

Because of the lower risk, non-invasive and minimally invasive surgery are becoming more popular. These procedures are more popular because they require fewer stitches and can be performed quickly. Nowadays, surgeons are performing single-port laparoscopic and robotic myomectomies/hysterectomies to remove larger fibroids. They can be easily removed by making small incisions and breaking them up with laparoscopic power mocellators. Minimally invasive procedures are less risky than open abdominal surgeries. These procedures allow for shorter hospital stays, so patients can return to work and continue their normal activities in a short time. These advantages are all cumulatively responsible for driving demand for minimally invasive surgery, and thereby, the market for laparoscopic power mocellators.

Due to an increasing number of cases of uterine fibroids and related surgeries as well as the increased awareness of treatment options among the general public, the U.S. was the dominant market in the region for laparoscopic power mocellators. In 2020, 85.0% of the total revenue share was held by the U.S. Uterine fibroids, which are the reason for hysterectomy, account for 39.0% in all hysterectomies that are performed each year in the U.S. According to the American Journal of Obstetrics and Gynology, uterine fibroids account for more than one third of all hysterectomies performed in the United States. The market for laparoscopic power mocellators is expected to grow in the future due to the increasing number of hysterectomy procedures. Technological advancements and the introduction of innovative products are key factors driving the country's laparoscopic power morcellator market growth.

Additionally, increasing awareness programs run by different organizations are increasing demand for fibroid treatments worldwide. July is recognized in the USA as Fibroid Awareness Month. This is a way to learn more about a very common gynecological condition, which can affect as many as 8 of 10 women before the age of 50. There have been many efforts to raise awareness about uterine fibroids in recent years. The White Dress Project and HealthyWomen.org are just a few of the prominent programs that focus on fibroids awareness and treatment.

The Healthy Women Project, for example, aims to educate and engage women about FDA-approved procedures and treatments. They are strong partners with patients and health professionals and they promote expanded audiences through program and campaign offerings via social media. All these initiatives by government and non-profit organisations for the treatment uterine fibroids will likely boost the growth rate of the market for laparoscopic powers morcellators over the forecast period.

Application Insights

Hysterectomy dominated the market in laparoscopic power morcellators, accounting for 70% of the total revenue share. This segment will also see the highest CAGR at 7.7% between 2021 and 2028. This is the best and most reliable permanent treatment for uterine fibroids. It has contributed to the segment's growth. Uterine fibroids can be permanently removed with this procedure. This procedure can make it impossible to become pregnant. According to the Journal of Obstetrics and Gynology Canada (JOCG), more than 41,000 hysterectomies take place each year in Canada. The forecast period will see a positive impact on segment growth due to the increasing number of hysterectomy procedures.

The myomectomy procedure can be used to remove fibroids and preserve the uterus. It allows patients to continue being fertile. Contrary to a hysterectomy, this procedure preserves fertility. There are many ways to perform myomectomy, depending on the size of the fibroids. Some surgeons now perform single-port (one-incision) robotic and laparoscopic myomectomies. Smaller fibroids can be removed by minor incisions. This is done by breaking them up into pieces, called morcellation. Segment growth will be boosted by a rise in non-invasive treatments preferences during the forecast period.

Regional Insights

North America was the dominant market for laparoscopic power mortillators in 2020, accounting for 52.8% of the total revenue. The forecast period will see a rise in laparoscopic power mocellators demand due to factors such as increased gynecological surgery/hospital visits, well-established healthcare facilities, and rising government initiatives. The region's laparoscopic power mocellator market is also growing due to the presence of key players and technologically advanced products.

The Asia Pacific market for laparoscopic power mocellators will experience the highest CAGR at 8.6% between 2021 and 2028. In the Asia Pacific, the rising number of patients with various conditions such as uterine fibroids and endometritis and subsequent rise in myomectomy, hysterectomy, and other complications is expected to increase the demand for laparoscopic powers morcellators over the next few years. There are also other factors that will support market growth in this region, such as an increase in hospitalizations, increased awareness about women's health and improved health spending.

Market Share Insights & Key Companies

These key players are focusing on research and development to create technologically advanced morcellators. Intuitive Surgical is a global healthcare company that specializes on minimally invasive and robotically-assisted surgery. In May 2018, Intuitive Surgical announced that the U.S. FDA approved its Single Port Platform - the da Vinci SP Surgical System, which can be used for a variety of urologic procedures. This system allows surgeons to use robotic-assisted technology for narrow and deep access to tissue.

Major players are also adopting different strategies, such as product launches, mergers, acquisitions and geographic expansion, to increase their share of the laparoscopic power morcellators market. Ethicon, Inc. and Olympus Corporation signed an agreement in October 2019 in which Olympus will purchase all business activities related to the Versapoint Elektrosurgery system. Minerva Surgical also acquired the Intrauterine Health Products segment of Boston Scientific Corporation in May 2020. These products include the Symphion Tissue Resection System, Resect Tissue Resection device, and the Genesys HTA System which are used to treat irregular uterine bleeding. These developments will have a significant impact on the market's growth during the forecast period. The market leaders in laparoscopic power morcellators include:

• Medtronic

• Karl Storz GmbH

• Richard Wolf GmbH

• LiNA Medical

• Lumenis (Boston Scientific Corporation).

• Nouvag AG

• Olympus Corporation

• RUDOLF Medical GmbH

Up Market Research published a new report titled “Laparoscopic Power Morcellators Market research report which is segmented by Application (Myomectomy, Hysterectomy), By Players/Companies Nouvag AG, Olympus Corporation, Richard Wolf GmbH, RUDOLF Medical GmbH, Medtronic, LiNA Medical, Lumenis (Boston Scientific Corporation), Karl Storz GmbH”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Laparoscopic Power Morcellators Market Report Segments:

The market is segmented by Application (Myomectomy, Hysterectomy).

Laparoscopic Power Morcellators Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Laparoscopic Power Morcellators Market

Overview of the regional outlook of the Laparoscopic Power Morcellators Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Laparoscopic Power Morcellators Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Laparoscopic Power Morcellators Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Myomectomy

                2. Hysterectomy

7. Market scenario by region, sub-region, and country.
8. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
9. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
10. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Laparoscopic Power Morcellators Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Laparoscopic Power Morcellators Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.